Trial Details
RECRUITINGBasic Information
| Clinical ID | c1223 |
|---|---|
| Identifier | NCT06609447 |
| Trial Title | The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DIETARY_SUPPLEMENT: VSL#3|DIETARY_SUPPLEMENT: Placebo|DRUG: Vedolizumab |
Participant Information
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-09-21 |
|---|---|
| Primary Completion Date | 2027-12-31 |
| Completion Date | 2027-12-31 |